Skip to main content
Clinical Trials/EUCTR2021-003238-35-NO
EUCTR2021-003238-35-NO
Active, not recruiting
Phase 1

Effects of supplemental oxygen on systemic and cerebral hemodynamics in experimental hypovolemia: A randomized, phase IV, crossover study to study the effect of supplemental oxygen vs. room air on cerebral and systemic hemodynamics in healthy volunteers > 18 years during experimental hypovolemia in the lower body negative pressure model of hypovolemia. - Supplemental oxygen in hypovolemia

Oslo University Hospital0 sites15 target enrollmentJune 22, 2021

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Hypovolemia is the condition under investigation. Hypovolemia is induced by the lower body negative pressure (LBNP)-model.
Sponsor
Oslo University Hospital
Enrollment
15
Status
Active, not recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 22, 2021
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
Oslo University Hospital

Eligibility Criteria

Inclusion Criteria

  • \- Age \> 18 years.
  • \- Age \< 50 years.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range 15
  • F.1\.3 Elderly (\>\=65 years) no
  • F.1\.3\.1 Number of subjects for this age range 0

Exclusion Criteria

  • 1\.Any medical condition limiting physical exertional capacity or requiring regular medication (allergy and contraceptives excepted).
  • 2\.Pregnancy.
  • 3\.Breastfeeding.
  • 4\.History of syncope (syncope of presumed vasovagal nature with known precipitating factor excepted).
  • 5\.Any known cardiac arrhythmia.
  • Prior/Concomitant Therapy
  • 6\.Any drug (contraceptives excepted) used on a regular basis for a chronic condition (allergy excepted).

Outcomes

Primary Outcomes

Not specified

Similar Trials